Hot Topics in Antitrust: What Counsel and Companies Should be Aware Of

Event Details


April 25, 2013

Add To Calendar



The attorneys of Arnall Golden Gregory’s Litigation Practice Group and Antitrust Litigation Practice Team held a complimentary Litigation Series webinar on Thursday, April 25, 2013 from 11:00 am – 12:00 pm EST.

AGG partners Allen I. Hirsch and Jeffrey S. Jacobovitz discussed the following key topics during the one hour presentation:

I. Overview

  • A brief synopsis of the relevant statutes:

    • Sherman §1 

    • Sherman §2 

    • Clayton §3 

    • Clayton §7 ‘

    • Robinson Patman 

    •  FTC A

  • The Applicable Test

    • Per Se vs. Rule of Reason

II. Criminal Cartel Cases

  • Increasing DOJ Enforcement 

    • Significant increase in jail sentences and fines over the last ten years 

    • Significant increase in international cartel cases and cooperation with international authorities

  • Fines 

    • What does this mean for companies 

  • Jail Sentences 

    • What does this mean for officers of companies 

  • Bid Rigging/Price Fixing 

  • As in-house counsel, what to look for 

  • How to Prevent These Cases 

  • What to do if a Search Warrant is being executed

III. Mergers & Acquisitions 

  • Clayton §7 – “Substantial Likelihood of Lessening Competition” 

  • DOJ/FTC Guideline – Current Climate for Merger Review 

  • Pre-Merger Conduct / “Gun Jumping” 

    • HSR – Filing Requirements / Market Definition

IV. Resale Price Maintenance

  • Pre-Leegin – The Days of Per Se Analysis 

  • Leegin – The Case that Changed It All 

  • Post Leegin – Confusing and Controversial

V. Health Care Enforcement 

  • DOJ/FTC Guidelines 

    • How do they impact on enforcement 

  • Provider Networks and Joint Ventures 

  • Professional Association Activity

  • What are the risks in participation 

  • Hospital Issues 

  • Hatch-Waxman Act 

    • Streamlined procedure for obtaining FDA approval of generic pharmaceuticals 

  • Settlements 

    • FTC and DOJ have challenged settlements as being anticompetitive; 

    • “reverse payments” or “pay for delay” agreements 

  • How to Avoid Government Scrutiny on a Settlement

VI. Intellectual Property 

  • Patent Antitrust Issues 

    • Recent enforcement cases 

    • Causes of action under Section 2

  • Patent Misuse 

    • Does the patent holder have to forfeit its right to enforce the patent 

  • Licensing of IP Rights 

    • Are license agreements contracts within the scope of Section 1 

  • Non-patent IP issues 

    • Copyrights and trademarks 

    • Antitrust counterclaims 

  • Areas of Exposure for In-House Counsel in the IP Area